Abstract:In this paper we report a successful application of machine learning approaches to the prediction of chemical carcinogenicity. Two different approaches, namely a support vector machine (SVM) and artificial neural network (ANN), were evaluated for predicting chemical carcinogenicity from molecular structure descriptors. A diverse set of 844 compounds, including 600 carcinogenic (CG+) and 244 noncarcinogenic (CG−) molecules, was used to estimate the accuracies of these approaches. The database was divided into two sets: the model construction set and the independent test set. Relevant molecular descriptors were selected by a hybrid feature selection method combining Fischer's score and Monte Carlo simulated annealing from a wide set of molecular descriptors, including physiochemical properties, constitutional, topological, and geometrical descriptors. The first model validation method was based a five-fold cross-validation method, in which the model construction set is split into five subsets. The five-fold cross-validation was used to select descriptors and optimise the model parameters by maximising the averaged overall accuracy. The final SVM model gave an averaged prediction accuracy of 90.7% for CG+ compounds, 81.6% for CG− compounds and 88.1% for the overall accuracy, while the corresponding ANN model provided an averaged prediction accuracy of 86.1% for CG+ compounds, 79.3% for CG− compounds and 84.2% for the overall accuracy. These results indicate that the hybrid feature selection method is very efficient and the selected descriptors are truly relevant to the carcinogenicity of compounds. Another model validation method, i.e. a hold-out method, was used to build the classification model using the selected descriptors and the optimised model parameters, in which the whole model construction set was used to build the classification model and the independent test set was used to test the predictive ability of the model. The SVM model gave a prediction accuracy of 87.6% for CG+ compounds, 79.1% for CG− compounds and 85.0% for the overall accuracy. The ANN model gave a prediction accuracy of 85.6% for CG+ compounds, 79.1% for CG− compounds and 83.6% for the overall accuracy. The results indicate that the built models are potentially useful for facilitating the prediction of chemical carcinogenicity of untested compounds.

In silico identification of human pregnane X receptor activators from molecular descriptors by machine learning approaches

In silico prediction of pregnane X receptor activators by machine learning approaches.

Predicting the Androgenicity of Structurally Diverse Compounds from Molecular Structure Using Different Classifiers

Identification of Hpxr Modulators Via Sar-Based Virtual Screening

Absorption, Distribution, Metabolism, Excretion, and Toxicity Evaluation in Drug Discovery. 14. Prediction of Human Pregnane X Receptor Activators by Using Naive Bayesian Classification Technique.

Machine Learning Based Models for High-Throughput Classification of Human Pregnane X Receptor Activators

Identification and Validation of Novel Human Pregnane X Receptor Activators among Prescribed Drugs Via Ligand-Based Virtual Screening

Prediction of bioactivities of microsomal prostaglandin E2 synthase-1 inhibitors by machine learning algorithms

Predictive Models for Identifying the Binding Activity of Structurally Diverse Chemicals to Human Pregnane X Receptor.

Prediction of HIV‐1 Protease Inhibitors Using Machine Learning Approaches

Prediction of Estrogen Receptor Agonists and Characterization of Associated Molecular Descriptors by Statistical Learning Methods.

Prediction of P2Y12 Antagonists Using a Novel Genetic Algorithm-Support Vector Machine Coupled Approach.

Initial Development of Automated Machine Learning-Assisted Prediction Tools for Aryl Hydrocarbon Receptor Activators

Predicting selective liver X receptor β agonists using multiple machine learning methods.

Prediction of Chemical Carcinogenicity by Machine Learning Approaches.

Prediction of Farnesoid X Receptor Disruptors with Machine Learning Methods.

Prediction of novel and selective TNF-alpha converting enzyme (TACE) inhibitors and characterization of correlative molecular descriptors by machine learning approaches

In Silico Prediction of Inhibition Activity of Pyrazine–Pyridine Biheteroaryls As VEGFR‐2 Inhibitors Based on Least Squares Support Vector Machines

Identifying hERG Potassium Channel Inhibitors by Machine Learning Methods

Applicability Domains Enhance Application of PPARγ Agonist Classifiers Trained by Drug-like Compounds to Environmental Chemicals.

Improvement in the screening performance of potential aryl hydrocarbon receptor ligands by using supervised machine learning